GlassScriptPhysician profile
Jennifer Irani
NPI 1790715191
$2,831.81
in general payments reported to CMS, 2019-2025
45 companies · $577 in 2025
The $577 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $626 · 2020: $79.63 · 2021: $119 · 2022: $472 · 2023: $332 · 2024: $627 · 2025: $577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,509 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,508.80 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $347.93 | 2019-2023 | |
| Coopersurgical, INC. | $247.98 | 2023-2025 | Endosee, Paragard T 380a, Ally II Ups |
| Pfizer INC. | $197.35 | 2019-2025 | |
| Intuitive Surgical, INC. | $193.10 | 2019 | |
| Shield Therapeutics INC | $126.44 | 2023-2025 | Accrufer |
| Biogen, INC. | $116.00 | 2025 | Zurzuvae |
| Astellas Pharma US INC | $101.58 | 2024-2025 | Veozah |
| Mayne Pharma Commercial LLC | $98.86 | 2021-2025 | |
| Ethicon US, LLC | $95.94 | 2020-2022 | |
| Myovant Sciences INC. | $83.09 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $78.84 | 2019-2025 | |
| Therapeuticsmd, INC. | $78.45 | 2019-2022 | |
| Millicent US INC | $73.02 | 2024 | Intrarosa |
| Organon LLC | $66.03 | 2022-2024 | |
| Agile Therapeutics, INC. | $65.33 | 2022-2023 | Twirla |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $64.47 | 2023-2025 | |
| Hologic Sales and Service, LLC | $61.81 | 2019-2025 | Acessa Provu System, Myosure Tissue Removal Device |
| Sage Therapeutics, LLC | $51.21 | 2019-2025 | Zurzuvae |
| Pacira Pharmaceuticals Incorporated | $46.78 | 2019-2022 | |
| Exeltis, USA INC. | $42.61 | 2022-2025 | Slynd |
| Solventum Corporation | $41.60 | 2025 | Prevena |
| Ascend Therapeutics US, LLC | $39.26 | 2022-2024 | |
| Mylan Pharmaceuticals INC. | $38.89 | 2022 | |
| Channel Medsystems, INC. | $38.14 | 2022 | |
| Merck Sharp & Dohme LLC | $35.14 | 2023-2024 | Gardasil 9, Gardasil |
| Gynesonics, INC. | $34.94 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Avion Pharmaceuticals | $26.98 | 2019-2023 | Balcoltra |
| Covidien LP | $26.93 | 2019 | |
| Heron Therapeutics, INC. | $25.31 | 2022 | |
| Duchesnay USA Incorporated | $25.00 | 2019 | |
| Optumhealth Care Solutions, LLC | $24.53 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Sanara Medtech INC. | $22.98 | 2025 | Celleraterx |
| Sumitomo Pharma America, INC. | $22.94 | 2024 | Myfembree |
| Organogenesis INC. | $20.88 | 2023 | Puraply |
| Supernus Pharmaceuticals, INC. | $19.20 | 2025 | Qelbree |
| Minerva Surgical, INC | $18.57 | 2022 | |
| Guard Medical INC. | $18.23 | 2025 | Npseal |
| Daiichi Sankyo INC. | $16.70 | 2019 | |
| Evofem Biosciences, INC. | $16.58 | 2022 | |
| Amag Pharmaceuticals, INC. | $15.98 | 2019 | |
| Exact Sciences Corporation | $14.81 | 2025 | Cologuard Collection Kit |
| Alydia Health | $14.00 | 2021 | |
| Teleflex LLC | $13.13 | 2019 | |
| Avanos Medical | $12.65 | 2019 | |
| Glaxosmithkline, LLC. | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Irani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.